ADPT

Adaptive Biotechnologies
ADPT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.36B
EV
$1.34B
Shares Outstanding
151.92M
Beta
1.76

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$11.14
P/E 2025E
-
P/Revenue 2025E
6.18x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Adaptive Biotechnologies Corporation

gainify
ADPT

Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biol...

Sector

Healthcare

Industry

Biotechnology

CEO

Robins, Chad

Employees

619

IPO Date

2019-06-27

Headquarters

1165 Eastlake Avenue East, Seattle, Washington, 98109, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on Threads
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.